05Sep 2019


  • Assistant Professor in Department of Obstetrics&Gynaecology, G.S.V.M Medical College, Kanpur.
  • Lecturer in Department of Pharmacology, Government Medical College, Kannauj.
  • Professor in Department of Pharmacology, Government Medical College, Kannauj.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Introduction:During pregnancy, Hypertension has become the most common medical problem and it is also remains main cause of maternal and fetal morbidity and mortality. It complicates almost 10% of all pregnancies. Aim:Present study was conducted to evaluate the prescribing pattern in pregnancy induced hypertension. Methods:A cross sectional study was carried out by evaluating prescription of 110 pregnant womens, who had diagnosed with PIH in Department of Pharmacology in collaboration with Department of Gynecology and Obstetrics. The data was analyzed by using SPSS software and results were expressed in percentage. Results:A Total of 110 Prescriptions were collected, among them, 56% of womens were diagnosed with stage-II hypertension (B.P≥160/≥100) and rest were diagnosed stage-I. In this, 77.2% of cases had received a single antihypertensive drug, while 18.1% had received two antihypertensive drugs& 4.5% received triple drugs therapy. Methyldopa was given in 35 patients (i.e. 31.8%. cases) as monotherapy and followed by Labetalol in 27 patients (24.5 %.cases). Combination of methyldopa and labetalol was the most common dual antihypertensive regimen given in 11.8 % of cases. Conclusion: During treatment with antihypertensive agents, prescriber should be very cautious as they are having history of causing foetal abnormality. Our study concluded that incidence of PIH is high and Methyldopa was the commonest drug given either alone or in combination therapy, as it is a safest during pregnancy. Patients also received other drugs for various purposes like, calcium supplements, iron, folic acid and multivitamin

  1. Kauntiz A.M, Hughes J.M, Grimes D.H, Smith J.C, Rochat R.W and Kaffrissen M.E. Causes of maternal mortality in the United States of American Journal of Obstetrics and Gynecology 1985; 65:605 - 612.
  2. Folic M, Folic N, Varjacic M, Jakovljevic M, Jankovic S. Antihypertensive drug therapy for hypertensive disorders in pregnancy. ActaMedica Medianae.2008;47(3):67-71.
  3. National high blood pressure education program working group, report on high blood pressure in American Journal of Obstetrics and Gynecology 1990; 163: 1691 - 1712
  4. Saudan P, Brown MA, Buddle ML et al. Does gestational hypertension become pre-eclampsia. British Journal of Obstetrics and Gynaecology,1998,105(11):1177-84 .
  5. Sharma R, Kapoor B, Verma U. drug utilization pattern during pregnancy in North India. Indian J Med Sci. 2006;60(7):277-86.
  6. ManjushaSajith, VandanaNimbargi, Amit Modi, RonakSumariya, AtmaramPawar. Incidence of pregnancy induced hypertension and prescription pattern of antihypertensive drugs in pregnancy.IJPSR;5(4):163-170.
  7. Tanuja VH, Santosh Kumar J, Manjunath S, Vinod Kumar CS. Drug utilization study of antihypertensives in obstetric practice in a tertiary care hospital. IJACPT. 2010;1(3):1006-10.
  8. Naveen Kumar T, Tadvi NA, Kaul R. Prescription pattern of drugs in pregnancy induced hypertension in a tertiary care hospital.IJBCP. 2013 Dec;2(6):783-787.
  9. Cvijic M, Horvat M, Jernejcic P, Verdenik I, Ger?ak K. Analysis of the intake of drugs used in hypertensive disorders during pregnancy. ZdravVestn 2010; 79: 412-18.
  10. Ray JG, Vermeulen MJ, Burrows EA, Burrows RF. Use of antihypertensive medications in Pregnancy and the risk of adverse perinatal outcomes: McMaster Outcome Study of Hypertension in Pregnancy 2 (MOS HIP 2). BMC Pregnancy and Childbirth 2001; 1:6.

[Shruti Gupta, CH.Nagesh and Ambrish Gupta. (2019); STUDY ON PRESCRIPTION PATTERN OF ANTI HYPERTENSIVES IN PATIENTS OF PREGNANCY INDUCED HYPERTENSION AT TERTIARY CARE HOSPITAL. Int. J. of Adv. Res. 7 (9). 194-197] (ISSN 2320-5407). www.journalijar.com

Mr. CH. Nagesh
Lecturer, Pharmacology Department, Government Medical College, kannauj, U.P


Article DOI: 10.21474/IJAR01/9647       DOI URL: http://dx.doi.org/10.21474/IJAR01/9647

Share this article